Eosinophilic Fasciitis/Generalized Morphea Overlap: A Rare Manifestation in a Patient with X-Linked Agammaglobulinemia
X-Linked Agammaglobulinemia (XLA) is a prototype of humoral immunodeficiency disorders manifested by recurrent sinopulmonary infections and characterized with low to absence of immunoglobulin production due to absence of B lymphocytes.
There are many reports of unusual complications of this genetic disease such as Pneumocystis carinii pneumonia, enteroviral infections with diverse manifestations, neutropenia during severe infections and also uncommon reports of some autoimmunities. Moreover, Rheumatological diseases are reported as a manifestation of XLA among which dermatomyositis is a known and expected condition. Other connective tissue diseases are rarely reported.
In this report, the researchers described a known case of XLA disease with progressive body pain, muscle ache, tender and tense skinand finally confirmed as a rare occurrence of Eosinophilic Fasciitis / Morphea Overlap.
2. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 1993;72(2):279-90.
3. Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, Ochs HD, Bonilla FA, Paris K, et al. Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol. 2014;34(6):627-32.
4. Zulian F. Systemic sclerosis and localized scleroderma in childhood. Rheum Dis Clin North Am 2008;34:239–255.
5. Bielsa I, Ariza A. Deep morphea. SeminCutan MedSurg 2007; 26:90–95.
6. Pinal-Fernandez I, Selva-O’ Callaghan A, Grau JM. Diagnosis and classification of eosinophilic fasciitis. Autoim¬mun Rev. 2014;13(4-5):379-82.
7. Bischoff L, Derk CT. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol. 2008;47(1):29-35.
8. Moulton SJ, Kransdorf MJ, Ginsburg WW, Abril A, Persellin S. Eosinophilic fasciitis: spectrum of MRI findings. AJR Am J Roentgenol. 2005;184(3):975-8.
9. R.E. Schmidt, B. Grimbacher, T. Witte. Autoimmunity and primaryimmunodeficiency: two sides of the same coin? Nat. Rev. Rheumatol. 14 (2017)7–18.
10. Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J Clin Immunol. 2018;38(1):96-128.
11. Arshi S, Nabavi M, Bemanian MH, Shakeri R, Taghvaei B, Ghalebaghi B, et al. Phenotyping and follow up of forty-seven Iranian patients with common variable immunodeficiency. Allergol Immunopathol (Madr). 2016;44(3):226-31.
12. Arason GJ, Jorgensen GH, Ludviksson BR. Primary immunodeficiency and autoimmunity: lessons from human diseases. Scand J Immunol. 2010;71(5):317-28.
13. Todoric K, Koontz JB, Mattox D, Tarrant TK. Autoimmunity in immunodeficiency. Curr Allergy Asthma Rep. 2013;13(4):361-70.
14. Amedei A, Romagnani C, Benagiano M, Azzurri A, Fomia F, Torrente F, et al. Preferential Th1 profile of T helper cell responses in X-linked (Bruton's) agammaglobulinemia. Eur J Immunol. 2001;31(6):1927-34.
15. Daniel RS, Lavery S, Maize JC Jr, Brown AN, Bolster MB. Unilateral eosinophilic fasciitis: an under-recognized subtype? J Clin Rheumatol. 2009;15(5):247-9.
16. Jensen E, Hess B, Hunziker T, Roos F, Helbling A. Eosinophile Fasziitis (Shulman-Syndrom) [Eosinophilic fasciitis (Shulman syndrome)]. Schweiz Med Wochenschr. 2000;130(5):156-60.
|Issue||Vol 4, No 2 (2021)|
|X-Linked Agammaglobulinemia Morphea Eosinophilic Fasciitis Rheumatologic Manifestation Sensorineural Hearing Loss|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|